Reinterpretation of Basal Glucocorticoid Feedback: Implications to Behavioral and Metabolic Disease

Kevin D. Laugero

Research output: Chapter in Book/Report/Conference proceedingChapter

13 Citations (Scopus)

Abstract

A number of metabolic (e.g., abdominal obesity) and psychological (e.g., depression) pathologies commonly present together and have been associated with dysregulation in the hypothalamo-pituitary-adrenal (HPA) axis. Glucocorticoid hormones represent the final product of this classic neuroendocrine axis, and these steroids modulate neuroendocrine, metabolic, and behavioral function. A primary characteristic of the HPA axis is a negative feedback loop, and glucocorticoids act through the brain to inhibit drive to this neuroendocrine system. Slight and chronic perturbations in glucocorticoid levels, below or above normal, throughout the body lead to metabolic (e.g., abdominal obesity) and behavioral (e.g., depression) pathology. Appropriate feedback in the HPA axis is, therefore, critical, and determining how and where glucocorticoids act to impart their feedback effects have been the focus of many laboratories. However, the answer to these questions remain, in part, elusive. In this chapter, I review findings that have led me to reinterpret glucocorticoid feedback in the HPA axis. I propose that, under basal (nonstress) conditions, glucocorticoid feedback is a consequence of the metabolic actions of the adrenal steroid, not a direct effect on brain. This new perspective may provide insight into the etiology of diseases such as major depression and the metabolic syndrome X, and might explain the commonly observed coexistence of affective and metabolic disturbances.

Original languageEnglish (US)
Title of host publicationVitamins and Hormones
Pages1-29
Number of pages29
Volume69
DOIs
StatePublished - 2004
Externally publishedYes

Publication series

NameVitamins and Hormones
Volume69
ISSN (Print)00836729

Fingerprint

Metabolic Diseases
Glucocorticoids
Feedback
Abdominal Obesity
Pathology
Brain
Metabolic Syndrome X
Steroids
Neurosecretory Systems
Hormones
Psychology

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Endocrinology
  • Physiology

Cite this

Laugero, K. D. (2004). Reinterpretation of Basal Glucocorticoid Feedback: Implications to Behavioral and Metabolic Disease. In Vitamins and Hormones (Vol. 69, pp. 1-29). (Vitamins and Hormones; Vol. 69). https://doi.org/10.1016/S0083-6729(04)69001-7

Reinterpretation of Basal Glucocorticoid Feedback : Implications to Behavioral and Metabolic Disease. / Laugero, Kevin D.

Vitamins and Hormones. Vol. 69 2004. p. 1-29 (Vitamins and Hormones; Vol. 69).

Research output: Chapter in Book/Report/Conference proceedingChapter

Laugero, KD 2004, Reinterpretation of Basal Glucocorticoid Feedback: Implications to Behavioral and Metabolic Disease. in Vitamins and Hormones. vol. 69, Vitamins and Hormones, vol. 69, pp. 1-29. https://doi.org/10.1016/S0083-6729(04)69001-7
Laugero, Kevin D. / Reinterpretation of Basal Glucocorticoid Feedback : Implications to Behavioral and Metabolic Disease. Vitamins and Hormones. Vol. 69 2004. pp. 1-29 (Vitamins and Hormones).
@inbook{850a9ae223bc4d2b9a8c1539fba7282c,
title = "Reinterpretation of Basal Glucocorticoid Feedback: Implications to Behavioral and Metabolic Disease",
abstract = "A number of metabolic (e.g., abdominal obesity) and psychological (e.g., depression) pathologies commonly present together and have been associated with dysregulation in the hypothalamo-pituitary-adrenal (HPA) axis. Glucocorticoid hormones represent the final product of this classic neuroendocrine axis, and these steroids modulate neuroendocrine, metabolic, and behavioral function. A primary characteristic of the HPA axis is a negative feedback loop, and glucocorticoids act through the brain to inhibit drive to this neuroendocrine system. Slight and chronic perturbations in glucocorticoid levels, below or above normal, throughout the body lead to metabolic (e.g., abdominal obesity) and behavioral (e.g., depression) pathology. Appropriate feedback in the HPA axis is, therefore, critical, and determining how and where glucocorticoids act to impart their feedback effects have been the focus of many laboratories. However, the answer to these questions remain, in part, elusive. In this chapter, I review findings that have led me to reinterpret glucocorticoid feedback in the HPA axis. I propose that, under basal (nonstress) conditions, glucocorticoid feedback is a consequence of the metabolic actions of the adrenal steroid, not a direct effect on brain. This new perspective may provide insight into the etiology of diseases such as major depression and the metabolic syndrome X, and might explain the commonly observed coexistence of affective and metabolic disturbances.",
author = "Laugero, {Kevin D.}",
year = "2004",
doi = "10.1016/S0083-6729(04)69001-7",
language = "English (US)",
isbn = "0127098690",
volume = "69",
series = "Vitamins and Hormones",
pages = "1--29",
booktitle = "Vitamins and Hormones",

}

TY - CHAP

T1 - Reinterpretation of Basal Glucocorticoid Feedback

T2 - Implications to Behavioral and Metabolic Disease

AU - Laugero, Kevin D.

PY - 2004

Y1 - 2004

N2 - A number of metabolic (e.g., abdominal obesity) and psychological (e.g., depression) pathologies commonly present together and have been associated with dysregulation in the hypothalamo-pituitary-adrenal (HPA) axis. Glucocorticoid hormones represent the final product of this classic neuroendocrine axis, and these steroids modulate neuroendocrine, metabolic, and behavioral function. A primary characteristic of the HPA axis is a negative feedback loop, and glucocorticoids act through the brain to inhibit drive to this neuroendocrine system. Slight and chronic perturbations in glucocorticoid levels, below or above normal, throughout the body lead to metabolic (e.g., abdominal obesity) and behavioral (e.g., depression) pathology. Appropriate feedback in the HPA axis is, therefore, critical, and determining how and where glucocorticoids act to impart their feedback effects have been the focus of many laboratories. However, the answer to these questions remain, in part, elusive. In this chapter, I review findings that have led me to reinterpret glucocorticoid feedback in the HPA axis. I propose that, under basal (nonstress) conditions, glucocorticoid feedback is a consequence of the metabolic actions of the adrenal steroid, not a direct effect on brain. This new perspective may provide insight into the etiology of diseases such as major depression and the metabolic syndrome X, and might explain the commonly observed coexistence of affective and metabolic disturbances.

AB - A number of metabolic (e.g., abdominal obesity) and psychological (e.g., depression) pathologies commonly present together and have been associated with dysregulation in the hypothalamo-pituitary-adrenal (HPA) axis. Glucocorticoid hormones represent the final product of this classic neuroendocrine axis, and these steroids modulate neuroendocrine, metabolic, and behavioral function. A primary characteristic of the HPA axis is a negative feedback loop, and glucocorticoids act through the brain to inhibit drive to this neuroendocrine system. Slight and chronic perturbations in glucocorticoid levels, below or above normal, throughout the body lead to metabolic (e.g., abdominal obesity) and behavioral (e.g., depression) pathology. Appropriate feedback in the HPA axis is, therefore, critical, and determining how and where glucocorticoids act to impart their feedback effects have been the focus of many laboratories. However, the answer to these questions remain, in part, elusive. In this chapter, I review findings that have led me to reinterpret glucocorticoid feedback in the HPA axis. I propose that, under basal (nonstress) conditions, glucocorticoid feedback is a consequence of the metabolic actions of the adrenal steroid, not a direct effect on brain. This new perspective may provide insight into the etiology of diseases such as major depression and the metabolic syndrome X, and might explain the commonly observed coexistence of affective and metabolic disturbances.

UR - http://www.scopus.com/inward/record.url?scp=4143103387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143103387&partnerID=8YFLogxK

U2 - 10.1016/S0083-6729(04)69001-7

DO - 10.1016/S0083-6729(04)69001-7

M3 - Chapter

C2 - 15196877

AN - SCOPUS:4143103387

SN - 0127098690

SN - 9780127098692

VL - 69

T3 - Vitamins and Hormones

SP - 1

EP - 29

BT - Vitamins and Hormones

ER -